Table 3 Association between combined risk genotypes of MDM2rs2279744 and MDM2rs937283 and recurrence risk in 1008 patients with SCCOP.

From: Modifying effect of mouse double minute-2 promoter variants on risk of recurrence for patients with squamous cell carcinoma of oropharynx

Combined MDM2 genotypes

No. of recurrences/no. of patients

5-year recurrence rate, %

Log-rank P value

aHR * (95% CI)

Low-risk group †

23/379

6

<0.0001

1.0

Medium-risk group

83/490

17

 

2.7 (1.7–4.2)

High-risk group

75/139

57

 

10.9 (6.8–17.4)

Trend test

  

<0.001

 

Combined MDM2 genotypes

No. of risk genotypes (no. of recurrences/no. of patients)

Genotypes of MDM2 polymorphisms

aHR * (95% CI)

  

rs2279744

rs937283

 

1

Low (9/205)

GG †

GG †

1.0

2

Low (5/71)

GG

AG

1.9 (0.3–3.2)

3

Medium (19/192)

GG

AA

3.4 (1.1–5.8)

4

Low (4/67)

GT

GG

1.4 (0.4–4.2)

5

Low (5/36)

GT

AG

2.6 (0.6–5.3)

6

Medium (28/99)

GT

AA

11.2 (6.5–20.1)

7

Medium (4/67)

TT

GG

1.9 (1.0–3.7)

8

Medium (32/132)

TT

AG

7.1 (3.7–13.6)

9

High (75/139)

TT

AA

26.8 (10.3–48.7)

  1. aHR, adjusted hazard ratio; CI, confidence interval.
  2. *Adjusted for age, sex, ethnicity, smoking status, alcohol use status, disease stage, comorbidity, and treatment.
  3. †Reference group.